GlobalGov › United States › Award

CERUS CORPORATION won LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION from the Government of United States

the Government of United States · United States government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$65.4M
Award Value
September 30, 2024
Award Date
Awarded
Status

Award Overview

CERUS CORPORATION was awarded LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION by the Government of United States in United States, tracked by GlobalGov. The award is valued at $65.4M. It was awarded on September 30, 2024. Classification: NAICS 541714, PSC 6505. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeCERUS CORPORATION
Awarding agencythe Government of United States
CountryUnited States
Award value$65.4M
Award dateSeptember 30, 2024
NAICS541714
PSC6505
Place of performanceUnited States
Last verifiedSeptember 1, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

United States market overview →Browse open opportunities →

Track every United States contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required